[Advances in research on metabolic associated fatty liver disease in 2025]. [PDF]
Rao HY, Zhao JM, Yu CH, Mi YQ, Wei L.
europepmc +1 more source
[Clinical practice and challenges from simple models to precise integration for serological evaluation of a non-invasive diagnosis of liver fibrosis]. [PDF]
Jin R, Ni WJ, Rui FJ, Li J.
europepmc +1 more source
[A review of research progress in integrated traditional Chinese and Western Medicine for liver diseases]. [PDF]
Zhang Q +6 more
europepmc +1 more source
Retrospective survey on occupational exposure among medical staff at a top tertiary general hospital in Nanning from 2020 to 2022 [PDF]
LIANG Xiong
core +1 more source
[Analysis of the Characteristics of the Oral Virome in Metabolic Dysfunction-Associated Fatty Liver Disease]. [PDF]
Tu Y, Niu C, Huang Z.
europepmc +1 more source
[Role of Kupffer cells in liver regeneration with metabolic associated fatty liver disease in mice]. [PDF]
Wang TW +7 more
europepmc +1 more source
[Predictive role of dynamic changes in liver stiffness measurement for liver-related endpoint events in chronic hepatitis B]. [PDF]
Sun CL +10 more
europepmc +1 more source
[Diagnosis and treatment of liver diseases in the era of artificial intelligence]. [PDF]
Ren LY, Chen DB, Chen HS.
europepmc +1 more source
[Introduction to the update points of the 2025 European Association for the Study of Liver clinical practice guidelines for the management of chronic hepatitis B infection]. [PDF]
Zhuang H.
europepmc +1 more source

